Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Use this BIIB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BIIB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BIIB SEC filings page. Lician reads the product cache first so this HTML stays unique to Biogen Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BIIB income, balance, and cash tables.